查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466692

核子医学市场：按产品、应用、类型和最终用户 - 2024-2030 年全球预测

Nuclear Medicine Market by Product (Diagnostic Products, Therapeutic Products), Application (Bone Metastasis, Cardiology, Endocrine Tumor), Type, End-Users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年核医市场规模为51.4亿美元，预计2024年将达55.1亿美元，2030年将达84.5亿美元，复合年增长率为7.35%。

核子医学市场是指涉及使用和生产用于医学影像诊断和治疗的放射性同位素的医疗保健产业。核子医学市场包括用于诊断影像的诊断放射性药物，例如正子断层扫描（PET）和单光子发射断层扫描（SPECT），以及用于治疗各种疾病的治疗性放射性药物。成像技术的进步和新型放射性药物的开发正在影响市场的开拓。需要精确诊断技术的慢性疾病的日益流行增加了对核医学的需求。患者和医疗保健提供者对核医学的认识和接受度的提高有助于市场的成长。然而，严格的监管障碍和高昂的产品开发成本限制了核子医学的采用。诊断影像设备和专业设施所需的高资本投资是一个市场挑战。此外，更安全、更有效的新型放射性同位素的生产正在吸引巨大的市场成长机会。将诊断和治疗能力整合到核製剂中的治疗诊断学的出现也创造了市场成长潜力。

主要市场统计
基准年[2023] 51.4亿美元
预测年份 [2024] 55.1亿美元
预测年份 [2030] 84.5亿美元
复合年增长率（%） 7.35%

产品诊断产品在核子医学的意义

核子医学诊断产品用于各种疾病的诊断和治疗，主要透过检测引入体内的放射性示踪剂的辐射。诊断示踪剂针对特定的器官、骨骼和组织，使医生能够了解身体各部位的功能并发现异常。核子医学中包含的治疗产品旨在治疗各种癌症和其他疾病。核子医学领域的治疗产品包括含有放射性同位素的放射性药物，这些放射性药物特异性针对并摧毁患病细胞，同时最大限度地减少对正常组织的损害。

最终用户医院和诊断中心的多功能应用

医院和诊断中心是核子医学市场最大的最终用户。医院和诊断中心需要诊断影像和标靶治疗应用来提供准确、快速的患者照护。研究机构透过探索新的放射性药物、新的成像技术和尖端治疗方法，为核子医学的发展做出了重大贡献。

区域洞察

在包括美国和加拿大在内的美洲地区，先进的医疗基础设施、高昂的医疗成本和丰富的放射性药物管道正在推动核医的需求。由于先进诊断技术的早期采用、研发的大量投资以及有利的报销政策，美国和加拿大仍然是核子医学最大的地区。欧洲市场的特征是经济高度发展、医疗保健体系完善、政府资金投入较多。在欧洲地区，对诊断和治疗放射性药物的需求透过成本控制措施和对实证临床结果的重视来平衡。在中东地区，阿拉伯联合大公国（阿联酋）和沙乌地阿拉伯是主要贡献者，透过努力改善核医学服务的可及性，为市场成长做出了贡献。在亚太地区，由于政府对医疗基础设施的投资以及癌症和心血管疾病发病率的上升，中国的核子医学产业正在迅速扩张。由于医疗意识的提高和医疗设施的改善，日本和印度的核医学领域正在不断发展。

FPNV定位矩阵

FPNV定位矩阵对于评估核医市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对核医市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.核医市场规模及预测如何？

2.核医市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3.核医市场的技术趋势与法规结构是什么？

4.核医市场主要厂商的市场占有率是多少？

5. 进入核医市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的癌症发生率和盛行率正在上升
      • PET 和 SPECT 在诊断心臟和神经系统疾病的使用增加
      • 国际组织的努力与支持核子医学的认识
    • 抑制因素
      • 核医学半衰期短
    • 机会
      • 治疗治疗诊断学在核子医学中日益普及
      • 持续的产品开发和专利技术进步
    • 任务
      • 新兴国家缺乏核子医学知识、培训和可用性
      • 全球缺乏熟练的放射科医生和医生
  • 市场区隔分析
    • 产品：诊断产品在核子医学的意义
    • 最终用户：医院和诊断中心的各种应用
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章核子医学市场：副产品

  • 诊断产品
  • 治疗产品

第七章 核子医学市场：依应用分类

  • 骨转移
  • 心臟病学
  • 内分泌肿瘤
  • 淋巴瘤
  • 肿瘤学
  • 甲状腺

第八章核子医学市场：依类型

  • 诊断
  • 治疗性的

第九章核医市场：依最终使用者分类

  • 医院和诊断中心
  • 调查机构

第十章美洲核子医学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太核子医学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲核子医学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Shine 与 Nucleus RadioPharma 签署供应协议
    • ITM与加拿大核能研究所成立新公司
    • Life Healthcare 将收购南非核子医学业务

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-A339DAEFAF4C

[184 Pages Report] The Nuclear Medicine Market size was estimated at USD 5.14 billion in 2023 and expected to reach USD 5.51 billion in 2024, at a CAGR 7.35% to reach USD 8.45 billion by 2030.

The nuclear medicine market refers to the healthcare industry concerned with the use and production of radioisotopes for medical imaging and therapy. The nuclear medicine market includes diagnostic radiopharmaceuticals used in imaging procedures including positron emission tomography (PET) and single-photon emission computed tomography (SPECT), as well as therapeutic radiopharmaceuticals for the treatment of various conditions. The advancements in imaging technologies and the development of new radiopharmaceuticals is influencing the market growth. The rising prevalence of chronic diseases requiring precise diagnostic techniques is enhancing the need for nuclear medicines. The increased awareness and acceptance of nuclear medicine procedures among patients and healthcare providers is contributing to market growth. However, stringent regulatory barriers and the high cost of product development has limited the adoption of nuclear medicines. High capital investment required for imaging equipment and specialized facilities is a challenging factor for the market. Moreover, manufacturing of novel radioisotopes with safer profiles and higher efficacy is attracting significant opportunities for market growth. The emergence of theranostics, integrating diagnostic and therapeutic capabilities within nuclear agents is also generating growth potential in the market.

KEY MARKET STATISTICS
Base Year [2023] USD 5.14 billion
Estimated Year [2024] USD 5.51 billion
Forecast Year [2030] USD 8.45 billion
CAGR (%) 7.35%

Product: Significance of diagnostic products in nuclear medicines

Diagnostic products in nuclear medicine are primarily used to diagnose and manage various diseases by detecting the radiation from a radioactive tracer that is introduced into the body. Diagnostic tracers target specific organs, bones, or tissues, allowing physicians to see how body parts function and detect anomalies. Therapeutic products in nuclear medicine are designed to treat various cancers and other diseases. Therapeutic products in nuclear medicine involve radiopharmaceuticals containing radioactive isotopes that specifically target and destroy diseased cells while minimizing damage to normal tissues.

End-Users: Diverse applications in hospitals and diagnostic centers

The hospitals, and diagnostic centers represent the largest end-user segment in the nuclear medicine market. Hospitals & diagnostic centers need diagnostic imaging and targeted therapeutic applications to provide accurate and prompt patient care. Research institutes significantly contribute to advancing nuclear medicine by exploring new radiopharmaceuticals, novel imaging techniques, and cutting-edge therapeutic methods.

Regional Insights

In the Americas region, the United States and Canada, the demand for nuclear medicine is driven by a sophisticated healthcare infrastructure, high healthcare expenditure, and a robust pipeline of radiopharmaceuticals. The United States and Canada remain the largest region for nuclear medicine due to its early adoption of advanced diagnostics, substantial investment in research and development, and favorable reimbursement policies. The European market is characterized by a high level of economic development, a well-established healthcare system, and significant government funding. In the European region, the demand for diagnostic and therapeutic radiopharmaceuticals is balanced by cost-containment measures and emphasis on evidence-based clinical outcomes. The United Arab Emirates (UAE) and Saudi Arabia are key contributors in the Middle East region, contributing to the market growth, with initiatives to increase accessibility to nuclear medical services. In the APAC region, china's nuclear medicine sector is rapidly expanding, due to government investment in healthcare infrastructure and an increasing incidence of cancer and cardiovascular diseases. Japan and India's nuclear medicine sector is growing due to rising healthcare awareness and improvements in healthcare facilities.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Nuclear Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Nuclear Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Nuclear Medicine Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Bayer AG, BJ Madan & Co., Bracco S.p.A., BWX Technologies, Inc. by Framatome, Cardinal Health, Inc., Curium, Eckert & Ziegler Radiopharma GmbH, Eczacibasi Monrol Nuclear Products Co., GE Healthcare, IBA Radiopharma Solutions, Institute of Isotopes Co., Ltd., Isotope Joint Stock Company, Isotopia Molecular Imaging, Jubilant DraxImage, Inc., Lantheus Holdings, Inc., Nordic Nanovector ASA by Thor Medical, Nordion (Canada) Inc. by Sotera Health LLC, Northstar Medical Technologies LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings LLC, Radiopharm Theranostics Limited, SHINE Technologies, LLC, and Sinotau Pharmaceuticals Group.

Market Segmentation & Coverage

This research report categorizes the Nuclear Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Diagnostic Products
      • PET
        • F-18
        • SR-82/RB-82
      • SPECT
        • GA-67
        • I-123
        • TC-99m
        • TL-201
    • Therapeutic Products
      • Alpha Emitters
      • Beta Emitters
        • I-131
        • Lu-117
        • Re-186
        • SM-153
        • Y-90
      • Brachytherapy
        • Cesium-131
        • Iodine-125
        • Iridium-192
        • Palladium-103
  • Application
    • Bone Metastasis
    • Cardiology
    • Endocrine Tumor
    • Lymphoma
    • Oncology
    • Thyroid
  • Type
    • Diagnostic
      • PET Procedures
      • SPECT Procedures
    • Therapeutic
      • Alpha Emitter Procedures
      • Beta Emitter Procedures
      • Brachytherapy Procedures
  • End-Users
    • Hospitals & Diagnostic Centers
    • Research institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Nuclear Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Nuclear Medicine Market?

3. What are the technology trends and regulatory frameworks in the Nuclear Medicine Market?

4. What is the market share of the leading vendors in the Nuclear Medicine Market?

5. Which modes and strategic moves are suitable for entering the Nuclear Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Incidence and Prevalence of Cancer Worldwide
      • 5.1.1.2. Increasing Use of PET and SPECT to Diagnose Heart disease and Neurological Disorders
      • 5.1.1.3. International Organizations' Initiatives and Awareness Supporting Nuclear Medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Shorter Half-Life of Nuclear Medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Popularity of Theranostics in Nuclear Medicine
      • 5.1.3.2. Continuous Product Developments and Advancements in Patented Technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Knowledge, Training, and Availability of Nuclear Medicine in Developing Countries
      • 5.1.4.2. Limited Availability of Skilled Radiologists and Practitioners Worldwide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significance of diagnostic products in nuclear medicines
    • 5.2.2. End-Users: Diverse applications in hospitals and diagnostic centers
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Nuclear Medicine Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostic Products
  • 6.3. Therapeutic Products

7. Nuclear Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Bone Metastasis
  • 7.3. Cardiology
  • 7.4. Endocrine Tumor
  • 7.5. Lymphoma
  • 7.6. Oncology
  • 7.7. Thyroid

8. Nuclear Medicine Market, by Type

  • 8.1. Introduction
  • 8.2. Diagnostic
  • 8.3. Therapeutic

9. Nuclear Medicine Market, by End-Users

  • 9.1. Introduction
  • 9.2. Hospitals & Diagnostic Centers
  • 9.3. Research institutes

10. Americas Nuclear Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Nuclear Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Nuclear Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Shine Reaches Supply Agreement with Nucleus RadioPharma
    • 13.3.2. ITM and Canadian Nuclear Labs Launch New Company
    • 13.3.3. Life Healthcare Set to Acquire Nuclear-medicine Operation in SA

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. NUCLEAR MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEAR MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NUCLEAR MEDICINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. NUCLEAR MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. NUCLEAR MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUCLEAR MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 85. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 86. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 87. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 88. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 89. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 90. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 91. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 92. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 93. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 94. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 95. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 96. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 97. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 98. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 99. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 100. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 101. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 102. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 103. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 104. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 105. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 108. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 109. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 110. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 111. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 112. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 113. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 114. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 115. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 116. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 117. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 118. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 119. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 124. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 125. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 126. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 127. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 128. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 129. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 130. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 131. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 134. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 135. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 136. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 137. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 138. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 139. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 140. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 141. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 142. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 143. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 144. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 145. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 150. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 151. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 152. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 153. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 154. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 155. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 158. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 159. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 160. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 161. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 162. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 163. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 164. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 165. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 166. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 167. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 168. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 169. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 174. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 175. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 176. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 177. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 178. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 179. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 182. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 183. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 184. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 185. CANADA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 186. CANADA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 187. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 188. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 189. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 190. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 191. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 192. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 193. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. CANADA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. CANADA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 198. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 199. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 200. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 201. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 202. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 203. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 206. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 207. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 208. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 209. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 210. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 211. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 212. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 213. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 214. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 215. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 216. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 217. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 222. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 223. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 224. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 225. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 226. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 227. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 230. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 231. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 232. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 233. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 234. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 235. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 236. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 237. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 238. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 239. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 240. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 241. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 246. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 247. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 248. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 249. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 250. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 251. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 252. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 279. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 280. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 281. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 282. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 283. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 284. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 285. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 286. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 287. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 288. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 289. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 290. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 291. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 292. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 293. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 298. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 299. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 300. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 301. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 302. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 303. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 306. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 307. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 308. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 309. CHINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 310. CHINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 311. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 312. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 313. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 314. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 315. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 316. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 317. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. CHINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. CHINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 322. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 323. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 324. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 325. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 326. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 327. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 328. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 329. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 330. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 331. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 332. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 333. INDIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 334. INDIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 335. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 336. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 337. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 338. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 339. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 340. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 341. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. INDIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. INDIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 346. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 347. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 348. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 349. INDIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 350. INDIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 351. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 352. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 353. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 354. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 355. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 356. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 357. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 358. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 359. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 360. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 361. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 362. I